|
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 7.620 CAD | 0.00% |
|
+20.57% | +13.73% |
| 09.02. | InnoCan Pharma: Neueste LPT-CBD-Studie mit Hunden in Fachzeitschrift veröffentlicht | MT |
| 27.01. | Innocan Pharma erwartet Börsennotierung an der NYSE American mit gleichzeitiger Emission | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 0.00% | +20.57% | -5.93% | -53.82% | +13.73% | -38.30% | -58.87% | -75.06% | - | 25.17 Mio. | |
| +0.17% | -1.72% | +0.68% | +1.44% | -3.23% | +23.18% | +210.44% | +401.71% | +1’359.24% | 929 Mrd. | |
| -0.45% | +1.44% | +10.88% | +24.25% | +17.64% | +55.91% | +52.76% | +46.15% | +139.10% | 587 Mrd. | |
| +1.76% | +3.61% | +6.81% | -0.37% | +1.32% | +20.03% | +53.25% | +121.66% | +340.28% | 409 Mrd. | |
| +0.18% | +1.98% | +4.37% | +25.63% | +9.93% | +22.60% | +30.21% | +15.20% | +44.20% | 374 Mrd. | |
| -0.51% | +8.34% | +7.07% | +10.70% | +9.11% | +28.44% | +32.42% | +105.15% | +259.61% | 320 Mrd. | |
| +0.34% | +4.49% | +9.71% | +18.74% | +14.60% | +31.19% | +55.64% | +52.43% | +73.96% | 311 Mrd. | |
| +1.82% | -0.43% | +9.41% | +30.66% | +15.34% | +46.26% | +12.75% | +61.88% | +147.62% | 301 Mrd. | |
| -0.74% | -1.05% | -15.73% | -1.58% | -5.38% | -45.95% | -37.77% | +32.87% | +81.46% | 219 Mrd. | |
| +0.82% | -3.94% | +11.87% | +9.64% | +12.80% | +26.80% | +53.79% | +55.64% | +155.11% | 199 Mrd. | |
| +2.09% | +1.63% | +27.81% | +23.96% | +26.27% | +48.90% | +82.22% | +131.69% | +73.28% | 192 Mrd. | |
| +0.40% | +1.32% | +6.53% | +10.06% | +10.76% | +8.03% | -36.33% | -20.56% | -6.06% | 157 Mrd. | |
| +5.69% | +2.84% | +11.97% | +12.43% | +8.41% | +7.07% | +64.51% | +129.68% | +490.50% | 125 Mrd. | |
| +1.47% | -2.02% | +7.28% | +30.20% | +12.61% | +12.69% | -15.01% | +1.25% | +0.90% | 124 Mrd. | |
| +0.79% | +1.11% | +20.18% | +21.31% | +19.65% | +53.79% | +50.04% | +37.19% | +23.20% | 118 Mrd. | |
| +0.37% | -2.96% | -4.56% | -13.33% | -5.81% | -25.12% | -12.11% | -0.80% | +11.63% | 111 Mrd. | |
| +0.02% | +1.71% | +8.01% | +9.16% | +12.60% | +25.65% | +158.84% | +80.30% | +719.00% | 99.9 Mrd. | |
| -1.41% | +0.56% | +6.94% | +26.60% | +14.48% | +31.47% | +31.91% | +48.99% | +0.67% | 58.01 Mrd. | |
| -0.87% | +1.61% | -7.82% | -7.42% | -2.25% | +27.98% | +29.95% | -36.01% | +315.26% | 55.97 Mrd. | |
| -0.20% | -1.05% | +8.79% | +63.88% | +23.74% | +114.05% | -23.85% | -16.45% | -52.51% | 53.62 Mrd. | |
| Durchschnitt | +0.59% | +1.61% | +6.21% | +12.11% | +10.32% | +23.73% | +36.74% | +58.65% | +219.81% | 237.18 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | +0.54% | +1.26% | +6.40% | +13.29% | +8.29% | +26.92% | +70.09% | +125.07% | +393.07% |
- Börse
- Aktien
- A41FTP Aktie
- Sektor InnoCan Pharma Corporation
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben